Choroid Plexus Enlargement and Allostatic Load in Schizophrenia.
allostatic load
choroid plexus
chronic stress
schizophrenia
Journal
Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760
Informations de publication
Date de publication:
10 04 2020
10 04 2020
Historique:
pubmed:
12
10
2019
medline:
15
5
2021
entrez:
12
10
2019
Statut:
ppublish
Résumé
Although schizophrenia is a brain disorder, increasing evidence suggests that there may be body-wide involvement in this illness. However, direct evidence of brain structures involved in the presumed peripheral-central interaction in schizophrenia is still unclear. Seventy-nine previously treatment-naïve first-episode schizophrenia patients who were within 2-week antipsychotics initial stabilization, and 41 age- and sex-matched healthy controls were enrolled in the study. Group differences in subcortical brain regional structures measured by MRI and the subclinical cardiovascular, metabolic, immune, and neuroendocrine biomarkers as indexed by allostatic load, and their associations were explored. Compared with controls, patients with schizophrenia had significantly higher allostatic load (P = .001). Lateral ventricle (P < .001), choroid plexus (P < .001), and thalamus volumes (P < .001) were significantly larger, whereas amygdala volume (P = .001) was significantly smaller in patients. The choroid plexus alone was significantly correlated with higher allostatic load after age, sex, education level, and the total intracranial volume were taken into account (t = 3.60, P < .001). Allostatic load was also significantly correlated with PANSS positive (r = 0.28, P = .016) and negative (r = -0.31, P = .008) symptoms, but in opposite directions. The peripheral multisystemic and central nervous system abnormalities in schizophrenia may interact through the choroid plexus during the early stage of the illness. The choroid plexus might provide a sensitive structural biomarker to study the treatment and prevention of brain-periphery interaction abnormalities in schizophrenia.
Identifiants
pubmed: 31603232
pii: 5585683
doi: 10.1093/schbul/sbz100
pmc: PMC7147577
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
722-731Subventions
Organisme : NIBIB NIH HHS
ID : R01 EB015611
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH112180
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH116948
Pays : United States
Organisme : NIH HHS
ID : S10 OD023696
Pays : United States
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
Am J Psychiatry. 2010 Jun;167(6):686-93
pubmed: 20360319
Rev Neurosci. 2016 Jun 1;27(4):397-409
pubmed: 26751865
Physiol Meas. 2018 Oct 30;39(11):115001
pubmed: 30222594
PLoS One. 2018 Jul 17;13(7):e0199922
pubmed: 30016331
Front Cell Neurosci. 2012 Aug 08;6:31
pubmed: 22891052
Psychoneuroendocrinology. 2017 Mar;77:105-111
pubmed: 28027496
Neuroimage. 2004 Jul;22(3):1060-75
pubmed: 15219578
Harv Rev Psychiatry. 2013 Nov-Dec;21(6):296-313
pubmed: 24201821
Science. 2014 Oct 3;346(6205):89-93
pubmed: 25147279
Exp Neurol. 2015 May;267:78-86
pubmed: 25747036
Nat Rev Endocrinol. 2011 Oct 18;8(2):114-26
pubmed: 22009159
Cell Stem Cell. 2016 Nov 3;19(5):643-652
pubmed: 27452173
Psychiatry Res. 2004 Jan 15;130(1):57-70
pubmed: 14972368
Horm Behav. 2003 Jan;43(1):2-15
pubmed: 12614627
Schizophr Res. 2017 Nov;189:84-90
pubmed: 28185786
Mol Psychiatry. 2016 Apr;21(4):554-64
pubmed: 26169974
JAMA Psychiatry. 2017 Mar 1;74(3):261-269
pubmed: 28097367
Front Psychiatry. 2014 Dec 03;5:173
pubmed: 25520673
Br J Psychiatry Suppl. 2004 Apr;47:S72-5
pubmed: 15056597
Mol Psychiatry. 2016 Apr;21(4):547-53
pubmed: 26033243
Neurosci Biobehav Rev. 2017 Sep;80:414-442
pubmed: 28645779
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4770-5
pubmed: 11287659
Endocrinology. 1994 Nov;135(5):2275-8
pubmed: 7956950
Eur J Pharmacol. 1990 Jun 8;181(3):247-52
pubmed: 2384133
Adv Drug Deliv Rev. 2004 Oct 14;56(12):1695-716
pubmed: 15381330
Fluids Barriers CNS. 2017 Mar 28;14(1):8
pubmed: 28351417
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Schizophr Res. 2014 Oct;159(1):36-42
pubmed: 25124520
Am J Psychiatry. 2013 Jun;170(6):609-15
pubmed: 23558429
Transl Psychiatry. 2018 Nov 12;8(1):246
pubmed: 30420620
CNS Neurol Disord Drug Targets. 2016;15(9):1151-1180
pubmed: 27633784
Stress. 2016 Sep;19(5):449-75
pubmed: 27294884
Mol Psychiatry. 2019 Jun;24(6):869-887
pubmed: 30116031
Biol Psychiatry. 2010 Feb 1;67(3):255-62
pubmed: 19897178
Psychoneuroendocrinology. 2015 Dec;62:376-80
pubmed: 26385108
Schizophr Res. 2019 Feb;204:439-441
pubmed: 30201550
Schizophr Bull. 2003;29(4):671-92
pubmed: 14989406
Neurobiol Dis. 2017 Nov;107:32-40
pubmed: 27546055
Brain Behav Immun. 2015 Nov;50:1-13
pubmed: 26116435
Arch Intern Med. 1997 Oct 27;157(19):2259-68
pubmed: 9343003
Transl Psychiatry. 2016 Nov 29;6(11):e964
pubmed: 27898074
Mol Psychiatry. 2019 Jun;24(6):776-794
pubmed: 29743584
Mol Psychiatry. 2010 Feb;15(2):118-9
pubmed: 20098438
Psychosom Med. 2017 Sep;79(7):770-776
pubmed: 28498274
Childs Nerv Syst. 1995 Sep;11(9):511-6
pubmed: 8529217
Neuropsychopharmacology. 2016 Jan;41(1):3-23
pubmed: 26076834
Neurosci Biobehav Rev. 2014 Sep;45:183-201
pubmed: 24950476
Int J Neurosci. 1993 Jul-Aug;71(1-4):87-92
pubmed: 8407158
Psychiatry Res. 2016 May 30;239:184-9
pubmed: 27010188
Psychoneuroendocrinology. 2018 Apr;90:35-42
pubmed: 29427955
J Neuropathol Exp Neurol. 2016 Mar;75(3):198-213
pubmed: 26888305
EMBO J. 2014 Jan 7;33(1):7-22
pubmed: 24357543
Br J Psychiatry. 2006 Jun;188:510-8
pubmed: 16738340
Psychoneuroendocrinology. 2018 Oct;96:166-172
pubmed: 29980008
BMJ. 2000 Jul 22;321(7255):199-204
pubmed: 10903648
Schizophr Bull. 2016 May;42(3):712-22
pubmed: 26834027
Schizophr Bull. 2013 Mar;39(2):306-18
pubmed: 22207632
Psychiatry Clin Neurosci. 2001 Feb;55(1):41-7
pubmed: 11235857
Psychoneuroendocrinology. 2015 Oct;60:120-9
pubmed: 26142568
Dev Psychol. 2008 Mar;44(2):330-43
pubmed: 18331126
Psychol Med. 2014 Jun;44(8):1577-90
pubmed: 24067164
J Cereb Blood Flow Metab. 1985 Sep;5(3):401-12
pubmed: 3928638
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
J Cereb Blood Flow Metab. 2009 Sep;29(9):1503-16
pubmed: 19471279
Eur J Pharmacol. 2004 Oct 1;500(1-3):399-411
pubmed: 15464048
Schizophr Res. 2015 Jun;165(1):45-51
pubmed: 25864953
Ann N Y Acad Sci. 2004 Dec;1032:1-7
pubmed: 15677391
Eur Psychiatry. 2017 Jan;39:1-10
pubmed: 27810612
Adv Drug Deliv Rev. 2004 Oct 14;56(12):1717-40
pubmed: 15381331
Antioxid Redox Signal. 2011 Sep 1;15(5):1285-303
pubmed: 21338320
BMC Neurosci. 2009 Nov 18;10:135
pubmed: 19922669
J Cereb Blood Flow Metab. 2012 Jan;32(1):93-104
pubmed: 21829211